Bone mineral density in pediatric patients with meningomyelocele

Childs Nerv Syst. 2016 Jan;32(1):111-9. doi: 10.1007/s00381-015-2930-0.

Abstract

Purpose: The aim of this study was to determine the bone mineral density (BMD) and the factors leading to reduction in BMD in children diagnosed with meningomyelocele.

Methods: A total of 31 patients with meningomyelocele (mean (SD) age, 8.5 (3.9) years; 51.6%were females) and 22 healthy children were included. BMD of femoral neck and spinal L1– L4 levels and markers for bone metabolism were recorded.

Results: BMD of femoral neck (p=0.001) and spinal L1–L4 (p = 0.01), serum calcium (p = 0.031), and urinary deoxypyridinoline (p=0.015) levels were significantly lower in patients than in controls. Mobilization was significantly reduced in lumbar (p=0.001) and thoracic (p=0.002) level meningomyelocele compared to controls, while a significant positive correlation was noted between BMD of spinal L1–L4 and mobility (r=0.58, p=0.015).

Conclusions: Our findings suggest a decrease in BMD in meningomyelocele patients being associated with osteoporosis rather than nutritional and hormonal factors and the negative impact of higher levels of lesion on the mobility.

MeSH terms

  • Absorptiometry, Photon
  • Adolescent
  • Adrenocorticotropic Hormone / blood
  • Amino Acids / urine
  • Anthropometry
  • Blood Chemical Analysis
  • Body Weight / physiology
  • Bone Density / physiology*
  • Calcium / blood
  • Calcium / urine
  • Case-Control Studies
  • Chi-Square Distribution
  • Child
  • Child, Preschool
  • Cholecalciferol / blood
  • Female
  • Follicle Stimulating Hormone / blood
  • Humans
  • Male
  • Meningomyelocele / blood
  • Meningomyelocele / diagnosis*
  • Meningomyelocele / physiopathology*
  • Meningomyelocele / urine
  • Statistics as Topic

Substances

  • Amino Acids
  • Cholecalciferol
  • Adrenocorticotropic Hormone
  • Follicle Stimulating Hormone
  • deoxypyridinoline
  • Calcium